CARDIO inCode-Score Clinical Publication on Polygenic Risk of Coronary Heart Disease.
GeninCode Plc announces the publication of a study in the American Journal of Preventive Cardiology. The study, using CARDIO inCode-Score®, found that the assessment tool can identify individuals with a high polygenic risk of Coronary Heart Disease (CHD) from a large, multiethnic cohort of 63,000 adults with no CHD history. The study was conducted by the Kaiser Permanente Division of Research over an average of 14 years.
April 05, 2024
4 Articles